Remicade
Manufacturing · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
PO Box 200, Titusville, New Jersey, 0856...Phone Number
(908) 218-6095Website
www.remicade.comRevenue
$17.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Remicade
REMICADE is a medication designed for the treatment of various autoimmune conditions, including moderately to severely active Crohn's disease, ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and chronic severe plaque psoriasis. The company provides comprehensive resources for both patients and healthcare professionals, including prescribing information, safety data, and cost support options. Intended clients include adults and pediatric patients suffering from these conditions, as well as healthcare providers seeking information on treatment options. REMICADE also offers personalized support through care coordinators to assist patients in managing their therapy.Explore more
Popular SearchesRemicadeJanssen Biotech IncSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Remicade your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Remicade is spiking on competitors!
Click to see if Remicade had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Remicade has new funding data
Remicade, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Remicade
Product Launch: Get notified when Remicade launches new products
Check if Remicade has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Remicade recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Remicade as Masked Content
Find 2 more new buyers
Compare Similar Companies to Remicade
Compare insights from companies similar to Remicade, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Remicade
$17.1M
51-200
Private
-
-
N/A
Company Profile Activity
Activity Insights
Remicade is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Remicade is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Remicade.
Remicade Tech Stack
A closer look at the technologies used by Remicade
Remicade News & Media
Investigation Report on China's Infliximab (Johnson & Johnson) Market, 2018-2022
DUBLIN, Nov. 1, 2018 /PRNewswire/ -- The "Investigation Report on China's Infliximab Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering. By 2017, there were over 5 million rheumatoid arthritis (RA) patients and over 4 million ankylosing spondylitis patients in...China's Infliximab Market, 2018-2022: Disease Overview, Sales, Prices & Forecasts
Dublin, Nov. 01, 2018 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Infliximab Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering.Investigation Report on China's Infliximab Market, 2018-2022 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Infliximab Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering. By 2017, there were over 5 million rheumatoid arthritis (RA) patients and over 4 million ankylosing spondylitis patients in China. As the incidence of Crohn's disease rises in recent years, over 100,000 people in China suffer from this disease every year. Infliximab is a human-mouse chimeric monoclonal antibody that works against tumor necrosis
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Remicade
Sign Up For FreeTo access detailed company insights
REMICADE is a medication designed for the treatment of various autoimmune conditions, including moderately to severely active Crohn's disease, ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and chronic severe plaque psoriasis. The company provides comprehensive resources for both patients and healthcare profe... Read More
